May 2016 Analysis

Industry Trend Analysis - Focus On Life Sciences Business Will Support Future Growth - MAY 2016

Bayer's strategical direction towards a pure life sciences company will increase its appeal to investors in 2016. De-diversification represents a growing trend within the pharmaceutical industry as companies look to focus their attention on core growth drivers. Bayer's crop science division will come under increasing pressure over the coming years as the merger between Dow Chemical and DuPont...